Emergence of Preexisting MET Y1230C Mutation as a Resistance Mechanism to Crizotinib in NSCLC with MET Exon 14 Skipping

标题
Emergence of Preexisting MET Y1230C Mutation as a Resistance Mechanism to Crizotinib in NSCLC with MET Exon 14 Skipping
作者
关键词
MET Y1230C, Resistance mutation, Crizotinib, MET, exon 14 skipping, Circulating tumor DNA
出版物
Journal of Thoracic Oncology
Volume 12, Issue 1, Pages 137-140
出版商
Elsevier BV
发表日期
2016-09-23
DOI
10.1016/j.jtho.2016.09.119

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started